文献速递腹部技术与安全CT

使用磁共振对比剂钆塞酸二钠进行CT胆管造影的体模研究

Computed Tomography Cholangiography Using the Magnetic Resonance Contrast Agent Gadoxetate Disodium: A Phantom Study.
PubMed 文献 · Invest Radiol · 2019-01-01

体模研究将4种浓度钆塞酸二钠置于水模中,用2台CT在多种单能和双能条件下成像并与12例碘对比剂临床CT胆管造影对比,发现最高浓度在各能量下均超过临床阈值,双能或低kV单能有助于增强信号。

要点

  • 钆塞酸二钠9.6 mg Gd/mL在各能量水平下对比度和CNR均超过临床碘对比剂阈值。
  • Force扫描仪图像噪声更低、CNR更高,Flash上部分浓度CNR不足。
  • 双能CT或低kV单能CT有助于增强钆塞酸二钠信号。

核心结论

  • 钆塞酸二钠有潜力作为CT胆管造影的对比剂,其CNR与临床碘对比剂相似。
  • 双能CT或低kV单能CT有助于增强信号。

研究设计与样本

  • 体模研究,将含4种浓度钆塞酸二钠(1.9、3.4、4.8、9.6 mg Gd/mL)的小瓶置于35×26 cm水模中。
  • 使用Siemens Somatom Flash和Force两台CT扫描仪成像,单能扫描70至140 kVp,双能扫描为90/150Sn(Force)和100/150(Flash),2个剂量水平(CTDIvol 13和23 mGy)。
  • 创建50 keV虚拟单能图像(Mono+),并与12例使用碘对比剂碘帕醇的临床CT胆管造影检查对比。

关键影像表现/征象

  • Force扫描仪图像噪声更低、CNR更高,Flash上部分浓度CNR不足。
  • 4.8 mg Gd/mL在Force上CNR足够,在Flash上不足。
  • 3.4 mg Gd/mL在Force低kV单能(<100 kVp)和双能50 keV有临床相关CNR,在Flash上不足。
  • 相似趋势在2个剂量水平均可见。

诊断标准与关键数值

  • 临床队列胆管相对于肝脏的平均对比度为239±107 HU,CNR为12.8±4.2。
  • 钆塞酸二钠最高浓度(9.6 mg Gd/mL)在所有能量水平下超过上述阈值。
  • 4.8 mg Gd/mL在Force上CNR足够,在Flash上不足。
  • 3.4 mg Gd/mL在Force低kV单能(<100 kVp)和双能50 keV有临床相关CNR,在Flash上不足。

临床应用与阅片要点

  • 双能CT或低kV单能CT有助于增强钆塞酸二钠信号。
  • Force扫描仪图像噪声更低、CNR更高,Flash上部分浓度CNR不足。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this work is to determine whether low doses of gadoxetate disodium (Eovist; Bayer Healthcare LLC, Whippany, NJ), a gadolinium-based contrast agent used for magnetic resonance liver imaging, can be visualized for computed tomography (CT) cholangiography using a phantom setup.

MATERIALS AND METHODS: Vials containing 4 concentrations of gadoxetate disodium (1.9, 3.4, 4.8, and 9.6 mg Gd/mL) were placed in a 35 × 26-cm water phantom and imaged on 2 CT scanners: Siemens Somatom Flash and Force (Siemens Healthcare, Erlangen, Germany). These concentrations correspond to the estimated concentration in the bile duct for a 40-, 70-, or 100-kg patient, and twice the concentration of a 100-kg patient, respectively. Single-energy (SE) scans were acquired at 70, 80, 90, 100, 120, and 140 kVp, and dual-energy scans were acquired at 90/150Sn (Force) and 100/150 (Flash) for 2 dose levels (CTDIvol 13 and 23 mGy). Virtual monoenergetic images at 50 keV were created (Mono+; Siemens Healthcare, Erlangen, Germany). The mean intensity and standard deviation for each concentration of gadoxetate disodium and the water background were extracted from each image set and used to compute the contrast and contrast-to-noise ratio (CNR). To determine whether the signal provided by gadoxetate disodium was clinically sufficient, the measures were compared with those acquired from 12 clinical CT cholangiography examinations performed with iodine-containing iodipamide meglumine.

RESULTS: From the retrospective clinical cohort, mean contrast (± standard deviation) of 239 ± 107 HU and CNR of 12.8 ± 4.2 were found in the bile duct relative to the liver. Comparing these metrics to the gadoxetate disodium samples, the highest concentration (9.6 mg Gd/mL) surpassed these thresholds at all energy levels. The 4.8 mg Gd/mL had sufficient CNR in the Force, but not in the Flash. The 3.4 mg Gd/mL had clinically relevant CNR at low kV of SE (<100 kVp) and 50 keV of dual energy in the Force but was insufficient in the Flash. Images acquired by the Force had a lower noise level and greater CNR compared with the Flash. Similar trends were seen at both dose levels.

CONCLUSIONS: Gadoxetate disodium shows promise as a viable contrast agent for CT cholangiography, with CNR similar to those seen clinically with an iodine-based contrast agent. Dual-energy CT or low kV SE-CT is helpful to enhance the signal.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Dilger SKN, Nelson N, Venkatesh SK, et al. Computed Tomography Cholangiography Using the Magnetic Resonance Contrast Agent Gadoxetate Disodium: A Phantom Study. Invest Radiol. 2019. PMID: 31261292. doi:10.1097/RLI.0000000000000580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。